Home › Companies › SANGAMO THERAPEUTICS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and SANGAMO THERAPEUTICS INC.’s Form 8-K, filed June 5, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 4, 2024: 13 items on SANGAMO THERAPEUTICS INC.’s Form 8-K, filed June 5, 2024: 9 elected · 4 passed (calculated).
Significant dissent: 1 director (20.7% against).
Notable dissent: 3 directors (11.7%, 11.6%, 10.0% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025
Explore SANGAMO THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are SANGAMO THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Courtney Beers, PhD. | 104,443,777 | 11,180,653 | 1,666,912 | -- | 38,717,741 | 90% | Elected | — |
| Elect Director: Robert F. Carey | 109,721,890 | 5,869,313 | 1,700,139 | -- | 38,717,741 | 95% | Elected | — |
| Elect Director: Kenneth J. Hillan, M.B. | 104,440,267 | 11,196,089 | 1,654,986 | -- | 38,717,741 | 90% | Elected | — |
| Elect Director: Margaret A. Horn, J.D. | 108,722,555 | 6,881,692 | 1,687,095 | -- | 38,717,741 | 94% | Elected | — |
| Elect Director: Alexander D. Macrae, M.B., Ch.B., Ph.D. | 102,677,999 | 13,424,026 | 1,189,317 | -- | 38,717,741 | 88% | Elected | — |
| Elect Director: John H. Markels, Ph.D. | 102,086,569 | 13,568,224 | 1,636,549 | -- | 38,717,741 | 88% | Elected | — |
| Elect Director: James R. Meyers | 103,985,480 | 11,583,362 | 1,722,500 | -- | 38,717,741 | 90% | Elected | — |
| Elect Director: H. Stewart Parker | 91,662,087 | 23,918,287 | 1,710,968 | -- | 38,717,741 | 79% | Elected | — |
| Elect Director: Karen L. Smith, M.D., Ph.D., M.B.A., L.L.M. | 104,262,373 | 11,342,802 | 1,686,167 | -- | 38,717,741 | 90% | Elected | — |
| 2. Approval, on an Advisory Basis, of the Compensation of the Named Executive Officers as Disclosed in the Proxy Statement | 101,303,168 | 15,057,209 | 930,965 | -- | 38,717,741 | 87% | Passed (calculated) | — |
| 3. Approval of the Amended 2018 Plan | 107,523,557 | 8,902,456 | 865,329 | -- | 38,717,741 | 92% | Passed (calculated) | — |
| 4. Approval of Amendment to Restated Certificate to Increase Authorized Number of Shares of Common Stock | 107,950,334 | 8,623,071 | 717,937 | -- | -- | 93% | Passed (calculated) | — |
| 5. Ratification of Appointment of Independent Registered Public Accounting Firm | 151,112,572 | 4,145,949 | 750,562 | -- | -- | 97% | Passed (calculated) | — |
Source: SANGAMO THERAPEUTICS INC., Form 8-K, filed with the SEC on June 5, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
143 asset managers disclosed a vote on at least one SANGAMO THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Prior year: 95.2% for (June 1, 2023 meeting) ▼ 6.8 pts
Description as filed by funds: To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: Alexander D. Macrae, M.B., Ch.B., Ph.D.
SANGAMO THERAPEUTICS INC.’s own tally for this item (“Elect Director: Alexander D. Macrae, M.B., Ch.B., Ph.D.”): 102,677,999 for, 13,424,026 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors: Each of the nominees for director listed in the Proxy Statement was elected by the votes set forth below:”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 42,307,993 for, 18,515 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,788,605 | 0 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,564,009 | 0 | 0 | 0 | For |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 494,291 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 400,000 | 0 | 0 | 0 | For |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 195,000 | 0 | 0 | 0 | For |
| MFS | 191,630 | 0 | 0 | 0 | For |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 142,198 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,421 | 0 | 0 | 0 | For |
| Jackson National | 65,565 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 54,511 | 0 | 0 | 0 | For |
| Voya | 53,715 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 35,760 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 35,597 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Description as filed by funds: To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: Courtney Beers, Ph.D.
SANGAMO THERAPEUTICS INC.’s own tally for this item (“Elect Director: Courtney Beers, PhD.”): 104,443,777 for, 11,180,653 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors: Each of the nominees for director listed in the Proxy Statement was elected by the votes set forth below:”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 42,307,993 for, 18,515 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,788,605 | 0 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,564,009 | 0 | 0 | 0 | For |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 494,291 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 400,000 | 0 | 0 | 0 | For |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 195,000 | 0 | 0 | 0 | For |
| MFS | 191,630 | 0 | 0 | 0 | For |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 142,198 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,421 | 0 | 0 | 0 | For |
| Jackson National | 65,565 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 54,511 | 0 | 0 | 0 | For |
| Voya | 53,715 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 35,760 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 35,597 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Prior year: 80.5% for (June 1, 2023 meeting) ▼ 1.2 pts
Description as filed by funds: To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: H. Stewart Parker
SANGAMO THERAPEUTICS INC.’s own tally for this item (“Elect Director: H. Stewart Parker”): 91,662,087 for, 23,918,287 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors: Each of the nominees for director listed in the Proxy Statement was elected by the votes set forth below:”
Support: 79% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 40,622,694 for, 1,685,299 against, 18,515 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,722,037 | 66,568 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,093,521 | 470,488 | 0 | 0 | Mixed |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 256,461 | 237,830 | 0 | 0 | Mixed |
| Delaware/Macquarie | 0 | 400,000 | 0 | 0 | Against |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 195,000 | 0 | 0 | Against |
| MFS | 191,630 | 0 | 0 | 0 | For |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 142,198 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 73,421 | 0 | 0 | Against |
| Jackson National | 65,565 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 54,511 | 0 | 0 | 0 | For |
| Voya | 0 | 53,715 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 0 | 35,760 | 0 | 0 | Against |
| Principal Exchange-Traded Funds | 0 | 35,597 | 0 | 0 | Against |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Prior year: 95.3% for (June 1, 2023 meeting) ▼ 5.3 pts
Description as filed by funds: To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: James R. Meyers
SANGAMO THERAPEUTICS INC.’s own tally for this item (“Elect Director: James R. Meyers”): 103,985,480 for, 11,583,362 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors: Each of the nominees for director listed in the Proxy Statement was elected by the votes set forth below:”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 42,307,993 for, 18,515 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,788,605 | 0 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,564,009 | 0 | 0 | 0 | For |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 494,291 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 400,000 | 0 | 0 | 0 | For |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 195,000 | 0 | 0 | 0 | For |
| MFS | 191,630 | 0 | 0 | 0 | For |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 142,198 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,421 | 0 | 0 | 0 | For |
| Jackson National | 65,565 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 54,511 | 0 | 0 | 0 | For |
| Voya | 53,715 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 35,760 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 35,597 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Prior year: 90.5% for (June 1, 2023 meeting) ▼ 2.2 pts
Description as filed by funds: To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: John H. Markels, Ph.D.
SANGAMO THERAPEUTICS INC.’s own tally for this item (“Elect Director: John H. Markels, Ph.D.”): 102,086,569 for, 13,568,224 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors: Each of the nominees for director listed in the Proxy Statement was elected by the votes set forth below:”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 41,627,191 for, 680,802 against, 18,515 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,788,605 | 0 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,142,521 | 421,488 | 0 | 0 | Mixed |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 494,291 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 400,000 | 0 | 0 | 0 | For |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 195,000 | 0 | 0 | Against |
| MFS | 191,630 | 0 | 0 | 0 | For |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 142,198 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,421 | 0 | 0 | 0 | For |
| Jackson National | 65,565 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 54,511 | 0 | 0 | Against |
| Voya | 53,715 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 35,760 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 35,597 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Prior year: 95.4% for (June 1, 2023 meeting) ▼ 5.2 pts
Description as filed by funds: To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: Karen L. Smith, M.D., Ph.D., M.B.A, L.L.M.
SANGAMO THERAPEUTICS INC.’s own tally for this item (“Elect Director: Karen L. Smith, M.D., Ph.D., M.B.A., L.L.M.”): 104,262,373 for, 11,342,802 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors: Each of the nominees for director listed in the Proxy Statement was elected by the votes set forth below:”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 42,307,993 for, 18,515 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,788,605 | 0 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,564,009 | 0 | 0 | 0 | For |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 494,291 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 400,000 | 0 | 0 | 0 | For |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 195,000 | 0 | 0 | 0 | For |
| MFS | 191,630 | 0 | 0 | 0 | For |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 142,198 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,421 | 0 | 0 | 0 | For |
| Jackson National | 65,565 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 54,511 | 0 | 0 | 0 | For |
| Voya | 53,715 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 35,760 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 35,597 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Prior year: 86.9% for (June 1, 2023 meeting) ▲ 3.4 pts
Description as filed by funds: To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: Kenneth J. Hillan, M.B., Ch.B.
SANGAMO THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kenneth J. Hillan, M.B.”): 104,440,267 for, 11,196,089 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors: Each of the nominees for director listed in the Proxy Statement was elected by the votes set forth below:”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 42,307,993 for, 18,515 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,788,605 | 0 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,564,009 | 0 | 0 | 0 | For |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 494,291 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 400,000 | 0 | 0 | 0 | For |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 195,000 | 0 | 0 | 0 | For |
| MFS | 191,630 | 0 | 0 | 0 | For |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 142,198 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,421 | 0 | 0 | 0 | For |
| Jackson National | 65,565 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 54,511 | 0 | 0 | 0 | For |
| Voya | 53,715 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 35,760 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 35,597 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 95.7% for (June 1, 2023 meeting) ▼ 1.6 pts
Description as filed by funds: To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: Margaret A. Horn, J.D.
SANGAMO THERAPEUTICS INC.’s own tally for this item (“Elect Director: Margaret A. Horn, J.D.”): 108,722,555 for, 6,881,692 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors: Each of the nominees for director listed in the Proxy Statement was elected by the votes set forth below:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 41,681,702 for, 626,291 against, 18,515 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,788,605 | 0 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,142,521 | 421,488 | 0 | 0 | Mixed |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 494,291 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 400,000 | 0 | 0 | 0 | For |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 195,000 | 0 | 0 | Against |
| MFS | 191,630 | 0 | 0 | 0 | For |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 142,198 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,421 | 0 | 0 | 0 | For |
| Jackson National | 65,565 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 54,511 | 0 | 0 | 0 | For |
| Voya | 53,715 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 35,760 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 35,597 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Prior year: 95.0% for (June 1, 2023 meeting) ▼ 0.1 pts
Description as filed by funds: To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2025 and until their successors are duly elected and qualified: Robert F. Carey
SANGAMO THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert F. Carey”): 109,721,890 for, 5,869,313 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors: Each of the nominees for director listed in the Proxy Statement was elected by the votes set forth below:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 42,307,993 for, 18,515 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,788,605 | 0 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,564,009 | 0 | 0 | 0 | For |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 494,291 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 400,000 | 0 | 0 | 0 | For |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 195,000 | 0 | 0 | 0 | For |
| MFS | 191,630 | 0 | 0 | 0 | For |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 142,198 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,421 | 0 | 0 | 0 | For |
| Jackson National | 65,565 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 54,511 | 0 | 0 | 0 | For |
| Voya | 53,715 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 35,760 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 35,597 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: To approve an amendment of our Seventh Amended and Restated Certificate of Incorporation, as amended, or the Restated Certificate, to increase the total number of shares of our common stock authorized for issuance from 640,000,000 to 960,000,000 shares;
SANGAMO THERAPEUTICS INC.’s own tally for this item (“4. Approval of Amendment to Restated Certificate to Increase Authorized Number of Shares of Common Stock”): 107,950,334 for, 8,623,071 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 41,886,505 for, 440,003 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,788,605 | 0 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,142,521 | 421,488 | 0 | 0 | Mixed |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 494,291 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 400,000 | 0 | 0 | 0 | For |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 195,000 | 0 | 0 | 0 | For |
| MFS | 191,630 | 0 | 0 | 0 | For |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 142,198 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,421 | 0 | 0 | 0 | For |
| Jackson National | 65,565 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 54,511 | 0 | 0 | 0 | For |
| Voya | 53,715 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 35,760 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 35,597 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: To approve the amendment and restatement of the Sangamo Therapeutics, Inc. 2018 Equity Incentive Plan, or the 2018 Plan, to, among other things, increase the aggregate number of shares of our common stock reserved for issuance under the 2018 Plan by 11,000,000 shares;
SANGAMO THERAPEUTICS INC.’s own tally for this item (“3. Approval of the Amended 2018 Plan”): 107,523,557 for, 8,902,456 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 42,105,620 for, 202,373 against, 18,515 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,788,605 | 0 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,564,009 | 0 | 0 | 0 | For |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 494,291 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 400,000 | 0 | 0 | 0 | For |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 195,000 | 0 | 0 | 0 | For |
| MFS | 0 | 191,630 | 0 | 0 | Against |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 142,198 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,421 | 0 | 0 | 0 | For |
| Jackson National | 65,565 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 54,511 | 0 | 0 | 0 | For |
| Voya | 53,715 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 35,760 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 35,597 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Prior year: 87.9% for (June 1, 2023 meeting) ▼ 0.8 pts
Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers, or NEOs, as described in the accompanying Proxy Statement;
SANGAMO THERAPEUTICS INC.’s own tally for this item (“2. Approval, on an Advisory Basis, of the Compensation of the Named Executive Officers as Disclosed in the Proxy Statement”): 101,303,168 for, 15,057,209 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,788,605 | 0 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,564,009 | 0 | 0 | 0 | For |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 494,291 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 400,000 | 0 | 0 | 0 | For |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 195,000 | 0 | 0 | 0 | For |
| MFS | 191,630 | 0 | 0 | 0 | For |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 120,289 | 21,909 | 0 | 0 | Mixed |
| AIG/SunAmerica | 73,421 | 0 | 0 | 0 | For |
| Jackson National | 0 | 65,565 | 0 | 0 | Against |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 54,511 | 0 | 0 | 0 | For |
| Voya | 53,715 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 35,760 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 35,597 | 0 | 0 | 0 | For |
Fund voting reports, all 45 managers: 42,197,134 for, 110,859 against, 18,515 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH ADVISORS LP | 19,165,582 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 18,174,966 | 0 | 0 | 0 | For |
| BlackRock | 4,666,194 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 3,302,791 | 0 | 0 | 0 | For |
| DE Shaw | 1,913,420 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 1,869,411 | 0 | 0 | 0 | For |
| State Street | 1,731,060 | 0 | 0 | 0 | For |
| Renaissance | 1,645,970 | 0 | 0 | 0 | For |
| Hudson Bay Capital Management LP | 1,373,500 | 0 | 0 | 0 | For |
| JPMorgan | 1,319,120 | 0 | 0 | 0 | For |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| HighTower Advisors, LLC | 781,543 | 0 | 0 | 0 | For |
| Nuveen | 737,464 | 0 | 0 | 0 | For |
| Northern Trust | 659,959 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 574,847 | 0 | 0 | 0 | For |
| Vanguard | 497,144 | 0 | 0 | 0 | For |
| Fidelity | 449,243 | 0 | 0 | 0 | For |
| Two Sigma | 430,469 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 400,000 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 0 | 351,643 | 0 | 0 | Against |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| Dimensional | 0 | 315,019 | 0 | 0 | Against |
| Invesco | 282,585 | 0 | 0 | 0 | For |
| T. Rowe Price | 278,704 | 0 | 0 | 0 | For |
| AllianceBernstein | 237,830 | 0 | 0 | 0 | For |
Institutional-manager reports, all 110 managers: 63,897,231 for, 691,919 against, 75,000 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 97.1% for (June 1, 2023 meeting) ▲ 0.2 pts
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024
SANGAMO THERAPEUTICS INC.’s own tally for this item (“5. Ratification of Appointment of Independent Registered Public Accounting Firm”): 151,112,572 for, 4,145,949 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 42,307,993 for, 18,515 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 17,689,343 | 0 | 0 | 0 | For |
| Vanguard | 11,788,605 | 0 | 0 | 0 | For |
| BlackRock | 4,123,396 | 0 | 0 | 0 | For |
| Fidelity | 3,564,009 | 0 | 0 | 0 | For |
| Charles Schwab | 1,242,792 | 0 | 0 | 0 | For |
| TIAA | 716,528 | 0 | 0 | 0 | For |
| Equitable | 494,291 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 400,000 | 0 | 0 | 0 | For |
| Federated Hermes | 335,119 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 254,025 | 0 | 0 | 0 | For |
| Invesco | 241,562 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 195,000 | 0 | 0 | 0 | For |
| MFS | 191,630 | 0 | 0 | 0 | For |
| T. Rowe Price | 154,104 | 0 | 0 | 0 | For |
| Lincoln Financial | 142,198 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,421 | 0 | 0 | 0 | For |
| Jackson National | 65,565 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,591 | 0 | 0 | 0 | For |
| Zacks Trust | 61,472 | 0 | 0 | 0 | For |
| Pacific Life | 57,864 | 0 | 0 | 0 | For |
| Northern Trust | 54,511 | 0 | 0 | 0 | For |
| Voya | 53,715 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,796 | 0 | 0 | 0 | For |
| John Hancock | 35,760 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 35,597 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 207,510,076 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | WASATCH FUNDS TRUST | 8.52% |
| 2 | Vanguard | 5.68% |
| 3 | BlackRock | 1.99% |
| 4 | Fidelity | 1.72% |
| 5 | Charles Schwab | 0.60% |
| 6 | TIAA | 0.35% |
| 7 | Equitable | 0.24% |
| 8 | Delaware/Macquarie | 0.19% |
| 9 | Federated Hermes | 0.16% |
| 10 | QUANTITATIVE MASTER SERIES LLC | 0.12% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | WASATCH ADVISORS LP | 9.24% |
| 2 | ARMISTICE CAPITAL, LLC | 8.76% |
| 3 | BlackRock | 2.25% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 1.59% |
| 5 | DE Shaw | 0.92% |
| 6 | ACADIAN ASSET MANAGEMENT LLC | 0.90% |
| 7 | State Street | 0.83% |
| 8 | Renaissance | 0.79% |
| 9 | Hudson Bay Capital Management LP | 0.66% |
| 10 | JPMorgan | 0.64% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Armistice Capital, LLC | 20,664,000 | 9.96% | Proxy statement (DEF 14A), proxy filed April 19, 2024 |
| Wasatch Advisors, Inc. | 20,134,294 | 9.70% | Proxy statement (DEF 14A), proxy filed April 19, 2024 |
| Biogen, Inc. | 14,652,466 | 7.06% | Proxy statement (DEF 14A), proxy filed April 19, 2024 |
| Vanguard Group | 11,615,150 | 5.60% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 4,556,208 | 2.20% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 3,363,791 | 1.62% | Form 13F, quarter ended March 31, 2024 |
| Alexander D. Macrae | 3,263,864 | 1.57% | Proxy statement (DEF 14A), proxy filed April 19, 2024 |
| Biogen MA Inc. | 3,250,000 | 1.57% | Schedule 13G, filed August 16, 2024 |
| D.E. Shaw | 3,067,435 | 1.48% | Form 13F, quarter ended March 31, 2024 |
| State Street | 2,751,804 | 1.33% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 207,510,076 shares outstanding, as reported by SANGAMO THERAPEUTICS INC. on its Form 10-Q dated May 6, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At SANGAMO THERAPEUTICS INC.'s shareholder meeting held June 4, 2024, in the 2023-2024 proxy season, 143 asset managers reported votes on at least one of its 13 ballot items in their SEC Form N-PX filings, covering 1,725 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers, or NEOs, as… — FOR was 87% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: SANGAMO THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SANGAMO THERAPEUTICS INC.’s 10-Q dated May 6, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
SANGAMO THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.
Proxy Votes Now, “SANGAMO THERAPEUTICS (SGMOQ) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/sangamo-therapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.